Ligands of Immunopharmacology

TLR7/8 agonist 4 (compound 41) is a potent TLR7/8 agonist. TLR7/8 agonist 4 has anti-cancer activityIC50&amp Target:TLR7 TLR8

TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b. TLR7/8-IN-1 can be used for the research of autoimmune diseaseIn VitroTLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor. TLR7/8-IN-1

TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b. TLR7/8-IN-1 can be used for the research of autoimmune diseaseIn VitroTLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor. TLR7/8-IN-1

TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b. TLR7/8-IN-1 can be used for the research of autoimmune diseaseIn VitroTLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor. TLR7/8-IN-1

TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b. TLR7/8-IN-1 can be used for the research of autoimmune diseaseIn VitroTLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor. TLR7/8-IN-1

TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b. TLR7/8-IN-1 can be used for the research of autoimmune diseaseIn VitroTLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor. TLR7/8-IN-1

TLR7/8/9-IN-1 is a potent and orally bioavailable small molecule antagonist ( IC 50 = 43 nM) of Toll-like receptors 7/8/9 (TLR7/8/9) .Form:Solid

TLR7/8/9-IN-1 is a potent and orally bioavailable small molecule antagonist ( IC 50 = 43 nM) of Toll-like receptors 7/8/9 (TLR7/8/9) .Form:Solid

TLR7/8/9-IN-1 is a potent and orally bioavailable small molecule antagonist ( IC 50 = 43 nM) of Toll-like receptors 7/8/9 (TLR7/8/9) .Form:Solid

TLR8 agonist 5 is a potent TLR8 agonist with an EC 50 value of 20 nM for HEK-Blue hTLR8. TLR8 agonist 5 activates the immune response.Form:Solid

TLR8 agonist 5 is a potent TLR8 agonist with an EC 50 value of 20 nM for HEK-Blue hTLR8. TLR8 agonist 5 activates the immune response.Form:Solid

TLR8 agonist 5 is a potent TLR8 agonist with an EC 50 value of 20 nM for HEK-Blue hTLR8. TLR8 agonist 5 activates the immune response.Form:Solid